Bovine sera used in the manufacture of biologicals: current concerns and policies of the U.S. Food and Drug Administration regarding the transmissible spongiform encephalopathies.

Developments in biological standardization

Volumn 99, Issue , 1999, Pages 41-44

  Asher, D M ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT;

ANIMAL; BLOOD; BOVINE SPONGIFORM ENCEPHALOPATHY; CATTLE; CATTLE DISEASE; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; FOOD AND DRUG ADMINISTRATION; HUMAN; REVIEW; RISK ASSESSMENT; STANDARD; UNITED STATES; ZOONOSIS;

ANIMALS; BIOLOGICAL PRODUCTS; BLOOD; CATTLE; CATTLE DISEASES; CREUTZFELDT-JAKOB SYNDROME; ENCEPHALOPATHY, BOVINE SPONGIFORM; HUMANS; RISK ASSESSMENT; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; ZOONOSES;

EID: 0032611299     PISSN: 03015149     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)